Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-05-10
2005-05-10
Whisenant, Ethan (Department: 1634)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024300, C435S006120
Reexamination Certificate
active
06891026
ABSTRACT:
The invention relates to a process for genotyping any HCV isolate present in a biological sample, previously identified as being HCV positive, and for classifying said isolate according to the percentage of homology with other HCV isolates, comprising the steps of:contacting said sample in which the ribonucleotides or deoxyribonucleotides have been made accessible, if need be, under suitable denaturation, with at least one probe from about 10 to about 40 nucleotides, with said probe being liable to hybridize to a region being in the domain extending from nucleotide at position −291 to nucleotide at position −66 of the 5′ untranslated region of one of the HCV isolates represented by their cDNA sequences, with said numbering of position beginning with the first ATG codon of the open reading frame encoding the HCV polyprotein, or with said probe being complementary to the above-defined probes,detecting the complexes possibly formed between said probe and the nucleotide sequence of the HCV isolate to be identified.
REFERENCES:
patent: 5043272 (1991-08-01), Hartley
patent: 5077193 (1991-12-01), Mishiro et al.
patent: 5176994 (1993-01-01), Mishiro et al.
patent: 5252743 (1993-10-01), Barrett et al.
patent: 5372928 (1994-12-01), Miyamura et al.
patent: 5427909 (1995-06-01), Okamoto et al.
patent: 5428145 (1995-06-01), Okamoto et al.
patent: 5527669 (1996-06-01), Resnick et al.
patent: 5550016 (1996-08-01), Okamoto et al.
patent: 5620852 (1997-04-01), Lin et al.
patent: 5629158 (1997-05-01), Uhlen
patent: 5846704 (1998-12-01), Maertens et al.
patent: 5871903 (1999-02-01), Miyamura et al.
patent: 6051696 (2000-04-01), Maertens et al.
patent: 6171784 (2001-01-01), Maertens et al.
patent: 6190864 (2001-02-01), Cha et al.
patent: 6297370 (2001-10-01), Cha et al.
patent: 6495670 (2002-12-01), Maertens et al.
patent: 6548244 (2003-04-01), Maertens et al.
patent: 0461863 (1991-12-01), None
patent: 0469348 (1992-02-01), None
patent: 529493 (1993-03-01), None
patent: WO 9202642 (1992-02-01), None
patent: WO 9210588 (1992-06-01), None
patent: WO 9219743 (1992-11-01), None
patent: WO 9323569 (1993-11-01), None
The Stratagene Catalog, p. 39 (1988).*
Martell et al., J. of Virology 66 (5) : 3225-3229 (May 1992).*
Sommer et al. Nucleic Acids Research 17 (16):6749 (1989).
Takamizawa et al., J. of Virology 65 (3):1105-1113 (Mar. 1991).
Okamoto et al., Japanese J. of Experimental Medicine 60: 167-177 (1990).
Bukh et al., PNAS 89:4942-4946 (1992).
Okamoto et al., Virology 188:331-341 (1992).
Cha et al., PNAS 89:7144-7148 (1992).
Inchaupse et al., Hepatology 14: 595-600 (1991).
Weiner et al., Lancet 335: 1-3 (1990).
Lee et al., J. of Clinical Microbiology 30 : 1602-1604 (1992).
Cha et al., J. of Clinical Microbiology 29(11):2528-2534 (1991).
Hu et al., J. Clin. Invest. 89, 2040-2045 (1992).
Nakao et al., J. of General Virology 72: 2105-2112 (1991).
Nedjar (1991) J. Virological Methods 35, 297-304.
Okamoto et al. (1992) J. Gen Virol. 73:673-79.
Okamoto et al., Japanese J. of Experimental Medicine 60 : 167-177 (1990).
Bukh et al., PNAS 89 :4942-4946 (1992).
Okamoto et al., J. of General Virology 72 : 2697-2704 (1991).
Okamoto et al., Virology 188 :331-341 (1992).
Cha et al., PNAS 89 : 7144-7148 (1992).
Inchaupse et al., Hepatology 14 : 595-600 (1991).
Weiner et al., Lancet 335 : 1-3 (1990).
Lee et al., J. of Clinical Microbiology 30 : 1602-1604 (1992).
Cha et al., J. of Clincal Microbiology 29(11):2528-2534 (1991).
Hu et al., J. Clin. Invest. 89, 2040-2045 (1992).
Nakao et al., J. of General Virology 72: 2105-2112 (1991).
Nedjar (1991) J. Virological Methods 35, 297-304.
Martell (1992) J. Virol. 66, 3225-3229.
Simmonds et al, J. of General Virology 74: 661-668 (1993).
Chan et al, J. of General Virology 73: 1131-1141 (1992).
Okamoto et al, J. of General Virology 7: 2697-2704 (1991).
Ogata et al, PNAS (USA) 88: 3392-3396 (1991).
Enomoto et al, Biochemical Biophysical Research Communications 170(3): 121-1025 (1990).
Choo et al, PNAS (USA) 88: 2451-2455 (1991).
Castillo et al. (1992) Journal of Virological Methods, vol. 38, No. 1, pp. 71-79.
Maertens Geert
Rossau Rudi
Stuyver Lieven
Van Heuverswyn Hugo
Innogenetics N.V.
Nixon & Vanderhye P.C.
Whisenant Ethan
LandOfFree
Process for typing of HCV isolates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for typing of HCV isolates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for typing of HCV isolates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3379536